Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation

Mayumi Ono(Kyushu University), Michihiko Kuwano(Kurume University)
Molecular Cancer Therapeutics
April 1, 2004
Cited by 309


Related Papers